Lupin gets tentative approval from USFDA for Sitagliptin and Metformin Hydrochloride Tablets
Sitagliptin and Metformin Hydrochloride Tablets, 50 mg/500 mg and 50 mg/1000 mg are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus